As shown in Figure 2A, increased TRIP13 expression was associated with a shorter OS in the following forms of cancer: KIRP, LIHC, ACC, skin cutaneous melanoma (SKCM), mesothelioma (MESO), LUAD, KIRC, and brain lower-grade glioma (LGG). Here, TRIP13 is linked to cutaneous melanoma.